BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10708121)

  • 1. Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1.
    Woo J; Iyer S; Mori N; Buelow R
    Transplantation; 2000 Feb; 69(4):623-33. PubMed ID: 10708121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
    Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation.
    Gerbitz A; Ewing P; Wilke A; Schubert T; Eissner G; Dietl B; Andreesen R; Cooke KR; Holler E
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):461-72. PubMed ID: 15205667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32).
    Woo J; Iyer S; Cornejo MC; Mori N; Gao L; Sipos I; Maines M; Buelow R
    Transpl Immunol; 1998 Jun; 6(2):84-93. PubMed ID: 9777696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity.
    Martins PN; Kessler H; Jurisch A; Reutzel-Selke A; Kramer J; Pascher A; Pratschke J; Neuhaus P; Volk HD; Tullius SG
    Transplant Proc; 2005; 37(1):384-6. PubMed ID: 15808653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Cytoprotective Cobalt Protoporphyrin Protect Skeletal Muscle and Muscle-derived Stem Cells From Ischemic Injury?
    Wilson HM; Welikson RE; Luo J; Kean TJ; Cao B; Dennis JE; Allen MD
    Clin Orthop Relat Res; 2015 Sep; 473(9):2908-19. PubMed ID: 26070773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway.
    Katori M; Buelow R; Ke B; Ma J; Coito AJ; Iyer S; Southard D; Busuttil RW; Kupiec-Weglinski JW
    Transplantation; 2002 Jan; 73(2):287-92. PubMed ID: 11821745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.
    Tullius SG; Nieminen-Kelhä M; Buelow R; Reutzel-Selke A; Martins PN; Pratschke J; Bachmann U; Lehmann M; Southard D; Iyer S; Schmidbauer G; Sawitzki B; Reinke P; Neuhaus P; Volk HD
    Transplantation; 2002 Sep; 74(5):591-8. PubMed ID: 12352873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme-oxygenase induction inhibits arteriolar thrombosis in vivo: effect of the non-substrate inducer cobalt protoporphyrin.
    Johns DG; Zelent D; Ao Z; Bradley BT; Cooke A; Contino L; Hu E; Douglas SA; Jaye MC
    Eur J Pharmacol; 2009 Mar; 606(1-3):109-14. PubMed ID: 19168058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
    Bédard EL; Jiang J; Parry N; Wang H; Liu W; Garcia B; Kim P; Chakrabarti S; Buelow R; Zhong R
    Transpl Int; 2005 Mar; 18(3):341-9. PubMed ID: 15730496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.
    Spilleboudt C; De Wilde V; Lewalle P; Cabanne L; Leclerc M; Beckerich F; Bories D; Cardoso S; Soares MP; Vokaer B; Hougardy JM; Flamand V; Racapé J; Abramowicz M; Maury S; Le Moine A
    Front Immunol; 2020; 11():579151. PubMed ID: 33537027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-dose of cobalt-protoporphyrin protects islet beta cells from glucocorticoid suppression.
    Hsu BR; Chen ST; Fu SH
    Transplant Proc; 2005 May; 37(4):1826-7. PubMed ID: 15919478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of heme oxygenase-1 to pancreas islet xenograft.
    Chen X; Zhang Z; Su C; Gu W; Li H; Zhou G
    J Surg Res; 2010 Dec; 164(2):336-43. PubMed ID: 20056245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of heme oxygenase-1 induction in vivo to pancreas islet xenograft].
    Su C; Chen X; Zhang ZY; Gu WQ; Zhang MJ; Zhou GW; Li XY; Ning G; Li HW
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1249-52. PubMed ID: 19781175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.
    Araujo JA; Meng L; Tward AD; Hancock WW; Zhai Y; Lee A; Ishikawa K; Iyer S; Buelow R; Busuttil RW; Shih DM; Lusis AJ; Kupiec-Weglinski JW
    J Immunol; 2003 Aug; 171(3):1572-80. PubMed ID: 12874251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts.
    Wagner M; Cadetg P; Ruf R; Mazzucchelli L; Ferrari P; Redaelli CA
    Kidney Int; 2003 Apr; 63(4):1564-73. PubMed ID: 12631374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.